Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.virusres.2020.198022

http://scihub22266oqcxt.onion/10.1016/j.virusres.2020.198022
suck pdf from google scholar
32417181!7228740!32417181
unlimited free pdf from europmc32417181    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid32417181      Virus+Res 2020 ; 285 (ä): 198022
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • COVID-19: CADD to the rescue #MMPMID32417181
  • Onawole AT; Sulaiman KO; Kolapo TU; Akinde FO; Adegoke RO
  • Virus Res 2020[Aug]; 285 (ä): 198022 PMID32417181show ga
  • The recent outbreak of the deadly COVID-19 disease, being caused by the novel coronavirus (SARS-CoV-2), has put the world on red alert as it keeps spreading and recording more fatalities. Research efforts are being carried out to curtail the disease from spreading as it has been declared as of global health emergency. Hence, there is an exigent need to identify and design drugs that are capable of curing the infection and hinder its continual spread across the globe. Herein, a computer-aided drug design tool known as the virtual screening method was used to screen a database of 44 million compounds to find compounds that have the potential to inhibit the surface glycoprotein responsible for virus entry and binding. The consensus scoring approach selected three compounds with promising physicochemical properties and favorable molecular interactions with the target protein. These selected compounds can undergo lead optimization to be further developed as drugs that can be used in treating the COVID-19 disease.
  • |*Drug Design[MESH]
  • |Antiviral Agents/*chemistry/metabolism/*pharmacology/toxicity[MESH]
  • |Betacoronavirus/*drug effects/physiology[MESH]
  • |COVID-19[MESH]
  • |COVID-19 Drug Treatment[MESH]
  • |Coronavirus Infections/*drug therapy[MESH]
  • |Drug Evaluation, Preclinical/methods[MESH]
  • |Humans[MESH]
  • |Ligands[MESH]
  • |Machine Learning[MESH]
  • |Models, Molecular[MESH]
  • |Molecular Docking Simulation[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*drug therapy[MESH]
  • |Protein Binding[MESH]
  • |Protein Structure, Tertiary[MESH]
  • |SARS-CoV-2[MESH]
  • |Spike Glycoprotein, Coronavirus/*antagonists & inhibitors/chemistry/metabolism[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box